Feasibility of SUPPORT-TBI
From Isolation to Connection: A Dyadic Approach to Enhancing Health After TBI
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Phase
Phase
- Phase 1
Contacts and Locations
Study Contact
Study Contact
- Name: Jessica Kersey, PhD, OTR/L
- Phone Number: 3142737540
- Email: jkersey@wustl.edu
Study Contact Backup
- Name: Curtis Comer, Clinical Research Coordinator I
- Phone Number: 3142733288
- Email: curtisccomer@wustl.edu
Study Locations
-
-
Missouri
-
St Louis, Missouri, United States, 63110
- Recruiting
- Washington University School of Medicine
-
Contact:
- Jessica Kersey, PhD, OTR/L
- Phone Number: 3142737540
- Email: jkersey@wustl.edu
-
Contact:
- Curtis Comer, Clinical Research Coordinator I
- Email: jkersey@wustl.edu
-
Principal Investigator:
- Jessica Kersey
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Age 18 or older
- Live in a community setting (not an institutional setting)
- Sustained a traumatic brain injury more than 6 months prior to enrollment
- Report mild-moderate TBI-related disability (score of 5 or greater) on the Glasgow Outcome Scale - Extended
- Report low social support (score of less than 50 on the MOS Social Support Survey)
Exclusion Criteria:
- Insufficient English language fluency
- Active substance use disorder (meets diagnostic criteria on the PRIME-MD MINI alcohol or non-alcoholic substances modules)
- Active, untreated psychotic disorder (meets diagnostic criteria on the PRIME-MD MINI psychotic disorders module)
- Severe memory impairment (score of less than 21 on the Montreal Cognitive Assessment)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: SUPPORT-TBI
This novel dyadic intervention incorporates essential elements of communication strategies, shared goals and activities, psychosocial support, peer mentorship, and problem-solving.
The person with TBI and a close supporter complete intervention procedures together and work to develop sustainable strategies for an effective support relationship.
The intervention is delivered in weekly 1-hour sessions for 12 consecutive weeks.
|
This novel dyadic intervention incorporates essential elements of communication strategies, shared goals and activities, psychosocial support, peer mentorship, and problem-solving.
The person with TBI and a close supporter complete intervention procedures together and work to develop sustainable strategies for an effective support relationship.
The intervention is delivered in weekly 1-hour sessions for 12 consecutive weeks.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
HEAL Treatment Expectancy Short Form
Time Frame: Immediately at the conclusion of each intervention session (included as part of the interventionist's session documentation)
|
6-item measure of intervention satisfaction with a 5-point Likert scale (range 6-30).
|
Immediately at the conclusion of each intervention session (included as part of the interventionist's session documentation)
|
|
Pittsburgh Rehabilitation Participation Scale
Time Frame: Immediately at the conclusion of each intervention session (included as part of the interventionist's session documentation)
|
Measure of engagement in intervention sessions (range 1-6); administered each session and combined into an intervention-wide engagement score.
|
Immediately at the conclusion of each intervention session (included as part of the interventionist's session documentation)
|
|
Study-specific fidelity checklist
Time Frame: Immediately at the conclusion of each intervention session (included as part of the interventionist's session documentation)
|
Checklist measuring the percentage of adherence to the outlined intervention elements; administered each session and combined into an intervention-wide adherence rate.
|
Immediately at the conclusion of each intervention session (included as part of the interventionist's session documentation)
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
MOS Social Support Survey
Time Frame: Baseline, Post-intervention (12 weeks)
|
19-item questionnaire examining perceived social support on a 5-point Likert scale with transformed scores (0-100).
|
Baseline, Post-intervention (12 weeks)
|
|
PROMIS Ability to Participate in Social Roles and Activities
Time Frame: Baseline, Post-intervention (12 weeks)
|
Computer adaptive test examining social participation abilities; scores reported as T-scores.
|
Baseline, Post-intervention (12 weeks)
|
|
PROMIS-29
Time Frame: Baseline, Post-intervention (12 weeks)
|
29-item measure of multiple health domains using a 5-point Likert scale and reported as T-scores.
|
Baseline, Post-intervention (12 weeks)
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Jessica Kersey, PhD, OTR/L, Washington University School of Medicine
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 202512160
- KL2TR002346 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- ICF
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.